Skip to Main Content

Author Details

Araceli Guerrero
Hospital Son Espases
2014
12
7
PMIDPaper TitleJournal TitlePublished Year
36269935Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials.J Clin Oncol2023
37639648Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate.J Clin Oncol2023
35050303Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts.JAMA Oncol2022
35469702High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium.Eur Urol2022
35427469High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.Lancet Oncol2022
35051385Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.Lancet Oncol2022
32981004Statistical control of processes applied to geometric uncertainties for CTV expansion margins determination in prostate cancer patients treated with VMAT: a prospective study in 57 patients.Clin Transl Oncol2021
33964325Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.Radiother Oncol2021
27598804Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.Int J Radiat Oncol Biol Phys2016
25702876High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.Lancet Oncol2015
26065609Correction to Lancet Oncol 2015; 16: 324. High-dose radiotherapy with shortterm or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.Lancet Oncol2015
24682792Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer.Clin Transl Oncol2014
  • 1 - 12 of 12

Recommended Authors

Johns Hopkins University
Career Start Year 2017
Number of shared co-authors 21
University of Michigan ann arbor
Career Start Year 2013
Number of shared co-authors 37
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 14
University of Miami Miller School of Medicine
Career Start Year 2010
Number of shared co-authors 10
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 4
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 17
The Institute of Cancer Research, Royal Marsden NHS Foundation Trust
Career Start Year 2005
Number of shared co-authors 1
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 12
Ghent University, GZA Ziekenhuizen
Career Start Year 2002
Number of shared co-authors 24
University of British Columbia
Career Start Year 2000
Number of shared co-authors 12
Houston Methodist Cancer Center
Career Start Year 2000
Number of shared co-authors 8
OHSU Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2000
Number of shared co-authors 15
Thomas Jefferson University Hospital
Career Start Year 1999
Number of shared co-authors 24
Stanford University
Career Start Year 1999
Number of shared co-authors 26
Sutter Medical Center Sacramento
Career Start Year 1998
Number of shared co-authors 28
University Hospitals Leuven
Career Start Year 1997
Number of shared co-authors 15
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1997
Number of shared co-authors 9
Princess Margaret Hospital, University of Toronto
Career Start Year 1995
Number of shared co-authors 16
Belgium International Drug Development Institute
Career Start Year 1995
Number of shared co-authors 18
Radboud University Medical Center
Career Start Year 1995
Number of shared co-authors 8
Duke University School of Medicine
Career Start Year 1993
Number of shared co-authors 29
Mayo Clinic
Career Start Year 1991
Number of shared co-authors 47
University of Montreal Health Center
Career Start Year 1990
Number of shared co-authors 12
Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 53
University of California los angeles
Career Start Year 1988
Number of shared co-authors 41
Duke University Medical Center
Career Start Year 1988
Number of shared co-authors 54
University of Washington and Fred Hutchinson Cancer Research Center
Career Start Year 1987
Number of shared co-authors 10
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 10
Northwestern University
Career Start Year 1984
Number of shared co-authors 10
University of Miami Miller School of Medicine
Career Start Year 1963
Number of shared co-authors 23

Collaborators

Hospital Universitari Vall d'Hebron
Co-authored papers 11
University Hospital La Princesa
Co-authored papers 11
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
UCSF Medical Center-Mount Zion
Co-authored papers 5
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University of Washington
Co-authored papers 5
University of California los angeles
Co-authored papers 5
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 5
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Co-authored papers 4
Pitie-Salpetriere Hospital, AP-HP.Sorbonne Universite
Co-authored papers 4
Amsterdam University Medical Centers, University of Amsterdam
Co-authored papers 4
universite Grenoble-Alpes (UGA)
Co-authored papers 4
University of Newcastle
Co-authored papers 3
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 3
Sir Charles Gairdner Hospital
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
University of Newcastle
Co-authored papers 3
University of California los angeles
Co-authored papers 2
University of California Los Angeles
Co-authored papers 2
Rush University Medical Center
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of Michigan ann arbor
Co-authored papers 2
Washington University School of Medicine
Co-authored papers 2
Cleveland Clinic
Co-authored papers 1
university of california los angeles Medical Center
Co-authored papers 1
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1